Literature DB >> 1747059

AIDS, drugs of abuse and the immune system: a complex immunotoxicological network.

R Pillai1, B S Nair, R R Watson.   

Abstract

Two of the most interesting questions often asked about AIDS is why many people do not become immunodeficient or get complicating disease when first infected with Human Immunodeficiency Virus (HIV) and what are the "risk factors" making some individuals more susceptible to the disease. A large majority of people with AIDS have a well established history of drug and alcohol abuse. Both drugs of abuse and alcohol have immunotoxic properties as evidenced by a number of studies. These include marked changes in the cellular, humoral and other components of the immune defense mechanism. Such a compromise of the immune system can render it susceptible to the development of AIDS after HIV infection. This paper reviews the evidence suggesting possible links between substance abuse and its immunotoxicology, and their possible roles in the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747059     DOI: 10.1007/bf02098025

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  111 in total

1.  Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression.

Authors:  R M Donahoe; J K Nicholson; J J Madden; F Donahoe; D A Shafer; D Gordon; P Bokos; A Falek
Journal:  Clin Immunol Immunopathol       Date:  1986-11

2.  Cocaine influences beta-endorphin levels and release.

Authors:  L J Forman; S Estilow
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

3.  Effect of alcohol on the mobilization of alveolar macrophages.

Authors:  J J Guarneri; G A Laurenzi
Journal:  J Lab Clin Med       Date:  1968-07

4.  The effect of beta-endorphin on natural cytotoxicity and antibody dependent cellular cytotoxicity.

Authors:  C J Froelich; A D Bankhurst
Journal:  Life Sci       Date:  1984-07-16       Impact factor: 5.037

5.  Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV?

Authors:  D N Fuchs; A Hausen; P Hengster; G J Reibnegger; B Unterweger; E R Werner; H Hinterhuber; M P Dierich; H Wachter
Journal:  Cancer Detect Prev       Date:  1988

6.  Acquired immunodeficiency syndrome in a heterosexual population in Zaire.

Authors:  P Piot; T C Quinn; H Taelman; F M Feinsod; K B Minlangu; O Wobin; N Mbendi; P Mazebo; K Ndangi; W Stevens
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

7.  Lymphopenia and lymphocyte transformation in alcoholics.

Authors:  G P Young; M B Van der Weyden; I S Rose; F J Dudley
Journal:  Experientia       Date:  1979-02-15

8.  Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.

Authors:  S H Smith; L S Harris; I M Uwaydah; A E Munson
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

9.  Effect of morphine on resistance to infection.

Authors:  E Tubaro; G Borelli; C Croce; G Cavallo; C Santiangeli
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

10.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors:  C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

2.  Psychological Distress Mediates the Effect of Alexithymia on 2-Year Change in HIV Viral Load.

Authors:  Roger C McIntosh; Gail Ironson; Michael Antoni; Betty Lai; Mahendra Kumar; Mary Ann Fletcher; Neil Schneiderman
Journal:  Int J Behav Med       Date:  2017-04

3.  An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.

Authors:  Xu Wang; Steven D Douglas; Jin-Song Peng; Dun-Jin Zhou; Qi Wan; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 4.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015

5.  Oral Health Behavior and Treatment Needs among Drug Addicts and Controls in Amritsar District: A Case-controlled Study.

Authors:  Preeti Chawla Arora; Komal Gurpreet Singh Ragi; Aman Arora; Ambika Gupta
Journal:  J Neurosci Rural Pract       Date:  2019 Apr-Jun

6.  Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.

Authors:  A S Reece
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-11-23

7.  Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers.

Authors:  Albert Stuart Reece
Journal:  Immun Ageing       Date:  2007-09-24       Impact factor: 6.400

8.  Experience of road and other trauma by the opiate dependent patient: a survey report.

Authors:  Albert S Reece
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.